However, the function of PDE6D in most cancer types remained elusive, and despite our study suggesting that interruption of the KRAS-PDE6D interaction in liver cancer might represent a novel therapeutic strategy [9], the expression and function of PDE6D in HCC was completely unknown. The gene discussed is PDE6D; the disease is hepatocellular carcinoma.